Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17219 | 547 | 31.3 | 69% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1220 | 8650 | TRIMETAZIDINE//DIABETIC CARDIOMYOPATHY//PERHEXILINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TRIMETAZIDINE | Author keyword | 332 | 73% | 46% | 252 |
| 2 | TRIMETAZIDINE MB | Author keyword | 11 | 100% | 1% | 6 |
| 3 | TRIMETASIDINE | Author keyword | 6 | 100% | 1% | 4 |
| 4 | TRIMETAZIDINE MR | Author keyword | 4 | 75% | 1% | 3 |
| 5 | TRIMETAZIDINE TMZ | Author keyword | 4 | 75% | 1% | 3 |
| 6 | UNITE TRANSPLANTAT EXPT | Address | 4 | 36% | 1% | 8 |
| 7 | TRIMETAZIDINE DIHYDROCHLORIDE | Author keyword | 2 | 44% | 1% | 4 |
| 8 | EA 2624 | Address | 2 | 67% | 0% | 2 |
| 9 | UR1154 | Address | 2 | 67% | 0% | 2 |
| 10 | CLIN CARDIOL HEART FAILURE UNIT | Address | 2 | 43% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TRIMETAZIDINE | 332 | 73% | 46% | 252 | Search TRIMETAZIDINE | Search TRIMETAZIDINE |
| 2 | TRIMETAZIDINE MB | 11 | 100% | 1% | 6 | Search TRIMETAZIDINE+MB | Search TRIMETAZIDINE+MB |
| 3 | TRIMETASIDINE | 6 | 100% | 1% | 4 | Search TRIMETASIDINE | Search TRIMETASIDINE |
| 4 | TRIMETAZIDINE MR | 4 | 75% | 1% | 3 | Search TRIMETAZIDINE+MR | Search TRIMETAZIDINE+MR |
| 5 | TRIMETAZIDINE TMZ | 4 | 75% | 1% | 3 | Search TRIMETAZIDINE+TMZ | Search TRIMETAZIDINE+TMZ |
| 6 | TRIMETAZIDINE DIHYDROCHLORIDE | 2 | 44% | 1% | 4 | Search TRIMETAZIDINE+DIHYDROCHLORIDE | Search TRIMETAZIDINE+DIHYDROCHLORIDE |
| 7 | METABOLIC AGENT | 1 | 100% | 0% | 2 | Search METABOLIC+AGENT | Search METABOLIC+AGENT |
| 8 | METABOLIC APPROACH | 1 | 50% | 0% | 2 | Search METABOLIC+APPROACH | Search METABOLIC+APPROACH |
| 9 | TRIMETAZIDINE HYDROCHLORIDE | 1 | 50% | 0% | 2 | Search TRIMETAZIDINE+HYDROCHLORIDE | Search TRIMETAZIDINE+HYDROCHLORIDE |
| 10 | METABOLIC THERAPY | 1 | 16% | 1% | 6 | Search METABOLIC+THERAPY | Search METABOLIC+THERAPY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TRIMETAZIDINE | 29 | 39% | 11% | 59 |
| 2 | COENZYME A THIOLASE | 10 | 32% | 5% | 25 |
| 3 | ARRESTED RAT HEART | 8 | 100% | 1% | 5 |
| 4 | ANTIANGINAL DRUG | 7 | 57% | 1% | 8 |
| 5 | TRIMPOL II | 6 | 100% | 1% | 4 |
| 6 | CARDIAC ENERGY METABOLISM | 4 | 28% | 2% | 13 |
| 7 | DRUG TRIMETAZIDINE | 3 | 100% | 1% | 3 |
| 8 | ERGOMETRIC PARAMETERS | 3 | 100% | 1% | 3 |
| 9 | EFFORT ANGINA | 3 | 33% | 1% | 8 |
| 10 | CONTRACTILE PROTEIN ABNORMALITIES | 3 | 60% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Trimetazidine and Cardioprotection: Facts and Perspectives | 2015 | 2 | 56 | 84% |
| Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine | 2008 | 14 | 146 | 86% |
| Efficacy Comparison of Trimetazidine with Therapeutic Alternatives in Stable Angina Pectoris: A Network Meta-Analysis | 2011 | 12 | 18 | 67% |
| Cardioprotective effects of trimetazidine: a review | 2003 | 24 | 56 | 95% |
| Metabolic therapy, in the treatment of ischaemic heart disease: the pharmacology of trimetazidine | 2003 | 56 | 63 | 48% |
| The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy | 2013 | 4 | 27 | 70% |
| Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease | 2014 | 1 | 61 | 66% |
| Trimetazidine for stable angina | 2005 | 23 | 74 | 51% |
| The efficacy of trimetazidine on stable angina pectoris: A meta-analysis of randomized clinical trials | 2014 | 1 | 22 | 50% |
| Effect of Therapy With Trimetazidine Modified Release on Quality of Life of Patients With Stable Effort Angina Survivors After Acute Myocardial Infarction. Results of PRIMA Study | 2010 | 0 | 3 | 100% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNITE TRANSPLANTAT EXPT | 4 | 36% | 1.5% | 8 |
| 2 | EA 2624 | 2 | 67% | 0.4% | 2 |
| 3 | UR1154 | 2 | 67% | 0.4% | 2 |
| 4 | CLIN CARDIOL HEART FAILURE UNIT | 2 | 43% | 0.5% | 3 |
| 5 | EA 2426 | 1 | 38% | 0.5% | 3 |
| 6 | RMN EXPLORAT FONCT | 1 | 50% | 0.4% | 2 |
| 7 | UNITE CHIRURG EXPT | 1 | 50% | 0.4% | 2 |
| 8 | UMR 1154 | 1 | 18% | 1.1% | 6 |
| 9 | GRP RECH TRANSPLANTAT MULTIVISCERALE | 1 | 40% | 0.4% | 2 |
| 10 | TRANSPLANTAT EXPT | 1 | 21% | 0.7% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000159221 | PROGRAM INTEGRAT CARDIAC METAB//HERITAGE MED 423//CARDIAC METABOLISM |
| 2 | 0.0000149811 | PERHEXILINE//HYDROXYPERHEXILINE//PERHEXILINE MALEATE |
| 3 | 0.0000147235 | MILDRONATE//MET 88//GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR |
| 4 | 0.0000113974 | RANOLAZINE//LATE SODIUM CURRENT//LATE I NA |
| 5 | 0.0000067051 | CARDIOMYOPATHIC HAMSTERS//CARDIOMYOPATHIC HAMSTER//HAMSTER CARDIOMYOPATHY |
| 6 | 0.0000056648 | META LEVEL INFERENCE//P TOLUENE SULFONYL CHLORIDE//CEREBRAL VASODILATOR |
| 7 | 0.0000053578 | H 3DIHYDROALPRENOLOL//PHYSIOPATHOL PHARMACOL CARDIOVASC EXPTL//UNHPI |
| 8 | 0.0000052133 | DOTARIZINE//DRUG INDUCED PARKINSONISM//CINNARIZINE |
| 9 | 0.0000051689 | GLUCOSE INSULIN POTASSIUM//THORAC PHYSIOL//GIK |
| 10 | 0.0000048918 | TRANSPLACENTAL MUTAGENICITY//ANTITUMOR PREPARATIONS//CANA3DTPA |